TABLE 1

Participant characteristics for each study component

Clinical status	Combined	Feasibility and known-groups validity^#		Concurrent validity^¶ and reliability⁺	Reliability^§			Responsiveness^ƒ
		Stable	Exacerbation	Stable	Combined	Stable	Exacerbation	Stable	Exacerbation
n	246	183	63	20	40	27	13	60	60
Male sex n	129	100	29	12	19	13	6	28	28
Age years (mean±sd)		31±10	33±11	33±10	33±10	32±9	33±10	33±10	-
FEV₁ % predicted (mean±sd)		64±23	54±20	54±19	54±19	57±22	53±18	55±17	42±16

^#: participants in outpatient clinic, completed AWESCORE once (clinically stable OR exacerbation). ^¶: participants in outpatient clinic, completed AWESCORE and CFQ-R once (clinically stable). ⁺: participants in outpatient clinic, completed AWESCORE twice 1 month apart (clinically stable). ^§: participants in outpatient clinic, completed AWESCORE twice at one visit (clinically stable) OR inpatient admission, completed AWESCORE twice within 24 h (exacerbation). ^ƒ: participants in outpatient clinic, completed AWESCORE once (clinically stable) and inpatient admission, completed AWESCORE once (exacerbation).